Novartis raises outlook

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Novartis raised its 2025 outlook, now expecting core profit to grow in the low teens, boosted by strong Q2 sales of key drugs like breast cancer treatment Kisqali.
Back to articles

Actual Topics

Mon, 21 Jul 2025 03:30:06 GMT

Chevron to proceed with turnaround plan

Chevron can move ahead with its $53B Hess deal after beating Exxon in court, giving it access to a major oil find and boosting CEO Mike Wirth's turnaround plan.

Fri, 18 Jul 2025 15:30:10 GMT

Walmart sees profit decline in Mexico

Walmart Mexico Q2 profit dropped 10%, missing forecasts, as weak consumer spending slowed recovery, despite an 8% rise in sales.

Subscribe to "Fundamental Analysis" feed

订阅
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台，SWFX和其它相关交易详情，
请致电我们或要求回电。
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台，SWFX和其它相关交易详情，
请致电我们或要求回电。
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.